Register for In-Person
(On Site) Attendance Register for Remote
(Virtual) Attendance
December 6 - 8, 2024
The Omni San Francisco • San Francisco, CA
Course# MDM25A02 - Department: Cardiology
Registration Fees
Early Bird 10/1/24
$750 Physicians
$550 Advanced Practice Professionals/Nurses
$450 Residents/Fellows
$1,000 Industry
Regular Fee 10/2/24
$800 Physicians
$600 Advanced Practice Professionals/Nurses
$500 Residents/Fellows
$1,000 Industry
On Site Fee 12/06/2024
$800 Physicians
$600 Advanced Practice Professionals/Nurses
$500 Residents/Fellows
$1,000 Industry
Cancellation Policy
Cancellations received in writing before Dec 5, 2024 will be refunded, less a $75 administrative fee. No refunds will be made on cancellations received after that date.
Please submit your cancellation request at https://tiny.ucsf.edu/cmehelp
Hot Topics for 2024!
Weight Loss Drugs and Heart Health, Heart Failure, Contemporary Management of Arrhythmias, Critical Care Cardiology, Mechanical Circulatory Support, Erectile Dysfunction and Heart Health, and Pulmonary Hypertension
Overview
Our 41st annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of weight loss drugs and heart health, heart failure, contemporary management of arrhythmias, critical care cardiology, mechanical circulatory support, erectile dysfunction and heart health, and pulmonary hypertension.
Our faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.
All sessions will be recorded and made available to participants for online viewing 30 days post course.
TARGET AUDIENCE
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.
Onsite and Remote Learning Options:
The course will be offered as a live conference. Registrants have the option to attend in person or to tune in remotely via zoom live stream during programming hours (Pacific Time). Login instructions along with the digital syllabus will be shared with attendees before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.
Objectives
- Providing the Best Management of Coronary Heart Disease, Hypertension, Lipid Disorders, Diabetes, Systolic and Diastolic Heart Failure, Atrial Fibrillation and Flutter, STEMI and Non-STEMI, Thromboembolic Disease;
- Refining Considerations for Atrial Fibrillation, Atrial Flutter, and Ventricular Tachycardia Ablation;
- Applying the Best Considerations of Percutaneous Interventions for Coronary Heart Disease;
- Improving the Use of Anti-Platelet and Anti-Coagulation Therapy for Cardiovascular Diseases;
- Recognizing Risk Stratification of Cardiovascular Disease;
- Optimizing the Management of Peripheral Artery Disease;
- Recognizing that Pathophysiology of Diseases and Treatment Options Differ among Racial and Ethnic Groups;
- Optimizing the Management of COVID-19 and its Cardiovascular Complications.
Accreditation
In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
UCSF designates this live activity for a maximum of 18.75 AMA PRA Category 1 Credits™. Physicians and Advanced Health Care Practitioners should claim only the credit commensurate with the extent of their participation in the activity.
Course Outline
| Friday, December 6, 2024 | ||
| 7:00 AM | Registration and Continental Breakfast | |
| 8:00 | Welcome and Symposium Overview | Peter Ganz, MD |
| Session: Frontiers in Interventional Cardiology | Chair: Lucas Zier, MD, MS | |
| 8:05 | Myocardial Infarction Without Obstructive Coronary Disease. What to Do? | Krishan Soni, MD, MBA |
| 8:45 | Complete Revascularization vs Culprit Only Revascularization: Understanding Each Strategy and When to Perform Each Approach | Ada Ip, MD |
| 9:25 | Orbita vs Orbita 2: Update on PCI for Stable CAD. | Lucas Zier, MD, MS |
| 10:05 | Coffee Break | |
| 10:20 | 2024 Updates on the Management of Valve Disease | Sammy Elmariah , MD, MPH |
| 11:00 | Surgical Management of Type A Aortic Dissection | Ramin Beygui, MD |
| 11:40 | Circulatory Support in Cardiogenic Shock: New Data and a New Era? | Connor O’Brien, MD |
| 12:20 PM | Lunch (on Your Own) | |
| Session: Managing Heart Failure | Chair: Jonathan Davis, MD, MPH | |
| 1:40 PM | HFrEF Management | Jonathan Davis, MD, MPH |
| 2:15 | HFpEF Management | Jacqueline DesJardin, MD |
| 2:50 | Approach to and Management of Cardiac Amyloid | Mandar Aras, MD, PhD |
| 3:25 | Coffee Break | |
| 3:40 | Approach to and Management of Hypertrophic Cardiomyopathy | Theodore Abraham, MD |
| 4:15 | Genetic Testing for Heart Failure, Who Should Be Tested and What are We Looking For? | Julianne Wojciak, LGCG, MS |
| 4:50 | New Drugs and Devices Coming Down Pipeline for Heart Failure | Liviu Klein, MD, MS |
| 5:25 PM | Adjourn | |
| Saturday, December 7, 2024 | ||
| 7:30 AM | Continental Breakfast | |
| 8:00 | Announcements | Peter Ganz, MD |
| Session: Advances and Controversies in Electrophysiology | Chair: Nora Goldschlager, MD | |
| 8:05 | Use and Misuse of Antiarrhythmic Drugs in 2025 | Gregory Marcus, MD, MAS |
| 8:45 | Extravascular Pacemakers and ICDs: Where Have All the Leads Gone? | Adam Oesterle, MD |
| 9:25 | Conduction System Pacing: Benefits, Outcomes and Risks | Joshua Moss, MD |
| 10:05 | Coffee Break | |
| 10:20 | Arrhythmogenic Cardiomyopathy | Melvin Scheinman, MD |
| 11:00 | What to Do with Incidentally Detected Atrial Fibrillation | Cara Pellegrini, MD |
| 11:40 | PVCs and non-Sustained VT. When to Worry. | Edward Gerstenfeld, MD, MS |
| 12:20 | Lunch (on your own) | |
| 1:40 PM | Achieving a Successful Ablation. Achieving a Successful Ablation. Patient Selection and Outcomes. | Thomas Dewland, MD |
| Session: Cardiovascular Risk Reduction and Prevention | Chair: Peter Ganz, MD | |
| 2:20 | Elliot Rapaport Keynote Lecture: How Failed Diabetes Drugs Led to a Revolution in Diabetes and Heart Failure Care. Convincing the FDA to Mandate Cardiovascular Outcome Trials for Diabetes Drug Approval | Steven Nissen, MD |
| 3:05 | New Prediction Tools from the AHA for Risk Assessment of Cardiovascular Disease | Peter Ganz, MD |
| 3:45 | Coffee Break | |
| 4:00 | Cardiovascular Disease in Type 1 Diabetes | Robert Eckel, MD |
| 4:40 | Pulmonary Hypertension, Contemporary Management and When to Refer | Marc Simon, MD, MS |
| 5:20 PM | Adjourn | |
| Sunday, December 8, 2024 | ||
| 7:30 AM | Continental Breakfast | |
| 8:00 | Announcements | Peter Ganz, MD |
| Session: Understanding and Managing Cardiovascular Risk | Chair: Peter Ganz, MD | |
| 8:05 | Sex diversity in heart-liver-metabolic axis risks and outcomes | Susan Cheng, MD, MMSc, MPH |
| 8:45 | PDE-5 inhibitors for Erectile Dysfunction: Do They Have Cardiovascular Protective Properties | Robert Kloner, MD, PhD |
| 9:25 | The Interplay of Cardiovascular and Kidney Disease | Julio Lamprea Montealegre, MD, PhD, MPH |
| 10:05 | Insights from Basic Science to Advance Understanding of Heart Failure | Arun Padmanabham, MD, PhD |
| 10:25 | Weight Loss Drugs and Heart Health | Martha Gulati, MD, MS |
| 11:05 | Management of Stroke - Updates | Lauren Patrick, MD |
| 11:45 | Adjourn | |
Course Chairs
(University of California San Francisco, unless indicated)
Jonathan Davis, MD, MPHS
Associate Professor of Medicine, Division of Cardiology;
Director, Heart Failure Program,
UCSF at Zuckerberg San Francisco General Hospital
Peter Ganz, MD, FACC
Professor, Division of Cardiology;
Director, Center of Excellence in Vascular Research,
UCSF at Zuckerberg San Francisco General Hospital
Nora F. Goldschlager, MD, FACC
Professor Emeritus of Medicine, Division of Cardiology,
UCSF at Zuckerberg San Francisco General Hospital
Lucas Zier, MD, MS
Associate Professor of Medicine, Division of Cardiology,
UCSF at Zuckerberg San Francisco General Hospital
Faculty
(University of California, San Francisco unless indicated)
Theodore Abraham, MD, FACC, FASE
Cardiologist; Co-Director, UCSF HCM Center of Excellence;
Director, UCSF Adult Cardiac Echocardiography Laboratory
Mandar Aras, MD, PhD
Associate Professor of Cardiology; Co-Director, UCSF Comprehensive Amyloidosis Program;
Clinical Cardiology Lead, UCSF HHT Center of Excellence
Ramin Beygui, MD
Professor of Surgery and Medical Director, Division of Adult Cardiothoracic Surgery
Susan Cheng, MD, MMSc, MPH
Professor and Vice Chair of Research Affairs, Department of Cardiology;
Erika J. Glazer Chair in Cardiovascular Health and Population Science; Director, Institute for Research on Healthy Aging;
Director, Population Health Sciences, Smidt Heart Institute at Cedars-Sinai, Los Angeles, CA
Jacqueline DesJardin, MD, MAS
Cardiologist, UCSF Adult Cardiac Echocardiography Laboratory
Thomas Dewland, MD
Associate Professor of Medicine, Division of Cardiology
Robert Eckel, MD
Emeritus Professor of Physiology and BioPhysics, and Charles A. Boettcher Endowed Chair in Atherosclerosis,
University of Colorado Anschutz Medical Campus, Aurora, CO
Sammy Elmariah, MD
Associate Professor of Medicine, Division of Cardiology
Edward P. Gerstenfeld, MD, MS, FACC
Melvin Scheinman Endowed Professor of Medicine; Chief, Cardiac Electrophysiology and Arrhythmia
Martha Gulati, MD, MS
Cardiologist, Director of Prevention & Associate Director,
Barbra Streisand Women's Heart Center Cedars-Sinai Heart Institute, Los Angeles, CA;
President-Elect, American Society for Preventive Cardiology
Ada Ip, MD
Assistant Professor of Medicine, Division of Cardiology
Liviu Klein, MD, MS
Professor of Medicine, Division of Cardiology
Robert Kloner, MD, PhD
Professor of Medicine, Keck School of Medicine, University of Southern California;
Chief Science Officer and Director, Cardiovascular Research, Huntington Medical Research Institutes, Pasadena, CA
Julio Lamprea Montealegre, MD, PhD, MPH
Cardiologist, Preventive Cardiology
Gregory Marcus, MD, MAS
Professor of Medicine, Division of Cardiology; Associate Chief of Cardiology for Research, UCSF Health
Joshua Moss, MD
Professor of Medicine, Division of Cardiology
Steven Nissen, MD
Chief Academic Officer, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute;
Lewis and Patricia Dickey Chair in Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
Connor O’Brien, MD
Assistant Professor of Medicine, Division of Cardiology
Adam Oesterle, MD
Assistant Professor of Medicine, Division of Cardiology
Arun Padmanabham, MD, PhD
Assistant Professor of Medicine, Division of Cardiology
Lauren Patrick, MD
Assistant Professor of Neurology
Cara Pellegrini, MD
Professor of Medicine, Division of Cardiology;
Director of Cardiac Electrophysiology, San Francisco VA
Melvin Scheinman, MD
Professor Emeritus; Director, Cardiac Genetic Arrhythmia Program
Marc Simon, MD, MS
Professor of Medicine, Division of Cardiology;
Director, Pulmonary Vascular Disease and the Pulmonary Hypertension Comprehensive Care Center
Krishan Soni, MD, MBA, FACC
Associate Professor of Medicine, Division of Cardiology
Julianne Wojciak, LGCG, MS
Genetic Counselor, UCSF Cardiovascular Genetics Program
Travel & Lodging
The Omni San Francisco
500 California Street
San Francisco CA 94104
Rates: $199- Deluxe/$399- California Suite
Phone: (415) 677-9494
Cutoff Date: November 21, 2024
Online Reservations Available Here
Please book online or call 415.677.9494 for reservations and inform the hotel that you are an attendee with the Advances in Heart Disease Course over December 6-8, 2024.
UNITED AIRLINES
UCSF has negotiated special fares with United Airlines for our course attendees.
Download Online Booking Instructions (.pdf)
Code ZPSR573928
Exhibitors
Exhibit Fee: $3,000
Email Contact for Exhibits [email protected]
Pay $3,000 fee via credit card
Exhibit Description
Exhibit Hours
(subject to updating)
| Friday, December 6, 2024 | |
| 7:00- 8:00AM | Continental Breakfast in Exhibit Area |
| 10:10- 10:40AM | Coffee Break in Exhibit Area |
| 3:15- 3:30PM | Coffee Break in Exhibit Area |
| Saturday, December 7, 2024 | |
| 7:00- 8:00AM | Continental Breakfast in Exhibit Area |
| 10:15- 10:30AM | Coffee Break in Exhibit Area |
| 2:45- 3:00PM | Coffee Break in Exhibit Area |
| Sunday, December 8, 2024 | |
| 7:00- 8:00AM | Continental Breakfast in Exhibit Area |
| 10:00- 10:20AM | Coffee Break in Exhibit Area |
Previous Courses